johnson and johnson Archives - Page 4 of 4 - Medically Speaking
Home Tags Posts tagged with "johnson and johnson"
Tag:

johnson and johnson

vaccination
Uncategorized

Biden boosting world vaccine sharing commitment to 80 million doses

by Medically Speaking Team
written by Medically Speaking Team

U.S. President Joe Biden said on Monday that the nation will share an additional 20 million doses of Covid-19 vaccines with the world in the coming six weeks as domestic demand for shots drops and global disparities in distribution have grown more evident.

The doses will come from existing production of Pfizer, Moderna or Johnson & Johnson vaccine stocks, marking the first time that US-controlled doses of vaccines authorized for use in the country will be shared overseas. It will boost the global vaccine sharing commitment form the US to 80 million.

“We know America will never be fully safe until the pandemic that’s raging globally is under control,” Biden said at the White House.

0 comment
0 FacebookTwitterPinterestEmail
johnson and johnson covid vaccine
Uncategorized

Canada pauses J & J vaccine for safety and quality verification

by Medically Speaking Team
written by Medically Speaking Team

Canada’s drug regulator on Friday said that it is halting the release of the country’s first shipment of the Johnson and Johnson vaccine to verify its safety and quality.

In a statement released on Friday, Health Canada said these were being withheld and “will only be released for distribution” once it  “is satisfied that they meet the department’s high standards for quality, safety and efficacy”.

This move came after Health Canada learnt that a drug substance was produced at the Emergent BioSolutions facility in Baltimore, Maryland, which has been inspected by the FDA with the agency noting multiple areas of concerns there.

Health Canada noted the substance is the “active ingredient that undergoes further processing before becoming the final product”, the vaccine. “The final Janssen vaccines were manufactured at a different site located outside of the US,” it said.

It added, “We will continue to ensure that products coming from the Emergent facility, or any other facility, will only be imported and distributed in Canada if they are of high quality and safe for use.”

It said the department is currently working with Janssen and the FDA to obtain all of the information it needs to complete its “assessment, prior to releasing the Janssen vaccines for distribution.”

Canada has also received 1.5 million doses of the AstraZeneca vaccine made at the same facility and Health Canada said it is also working with them “to ensure the facility meets manufacturing standards, and that all vaccine supplies for Canada are of high quality”.

0 comment
0 FacebookTwitterPinterestEmail
johnson and johnson covid vaccine
Uncategorized

J&J shots to be imported in India possibly by June-July

by Medically Speaking Team
written by Medically Speaking Team

Pharma giant Johnson and Johnson’s single shot Covid-19 vaccine will expectedly arrive by June or July, 2021, reports ANI.

According to the report, the Secretary of Department of Biotechnology from the Ministry of Science and Technology, Renu Swarup told ANI, “The Johnson and Johnson vaccines are expected to be imported in India by June-July 2021. Johnson and Johnson is working closely with Biological E to facilitate the ongoing tech transfer to India.”

India said it would fast-track emergency approvals for Covid-19 vaccines authorized by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson and Moderna shots.

0 comment
0 FacebookTwitterPinterestEmail
johnson and johnson covid vaccine
Uncategorized

J&J seeks permission for phase 3 trial of Covid-19 vaccine

by Medically Speaking Team
written by Medically Speaking Team

American Pharma giant Johnson and Johnson seeks permission for phase 3 trial of its single-shot Covid-19 vaccine on Monday.

The company has sought grant of import license in India, reported PTI.

They said the company has sought an early meeting of the subject expert committee on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application.

J&J is the only manufacturer with single-shot vaccine against Covid-19, though the vaccine has been banned in certain countries due to blood clot rumours.

0 comment
0 FacebookTwitterPinterestEmail
johnson and johnson covid vaccine
Uncategorized

Johnson & Johnson to start trials of Covid vaccine in India

by Medically Speaking Team
written by Medically Speaking Team

Johnson and Johnson will soon begin clinical trials of its single-shot Covid-19 vaccine in India, the company told Indian regulators.

In a letter to India’s Central Drugs Standard Control Organization (CDSCO), the U.S. based company said that it would “very shortly apply for permission to conduct clinical bridging trials in India,” reported Indian Express.

The report comes in as many vaccination centres in India suffer a shortage of vaccine supplies as the country of 1.3 billion is battling a second wave of Covid-19 infections that has eclipsed the first.

0 comment
0 FacebookTwitterPinterestEmail
moderna covid-19 vaccine
Uncategorized

Avoid rumors and get vaccinated

by Medically Speaking Team
written by Medically Speaking Team

By Dr.Dhiren Gupta

Two worries are creeping among covishield vaccines recipients . One is of getting break through infections and second about thrombosis post vaccination ( in young females ) .Irresponsible statements from various agencies / social media added confusion to these issues .

Use of the vaccine has been suspended for individuals younger than 55 or 60 years in several European countries and in Canada after reports of a prothrombotic disorder and thrombocytopenia, mainly in younger individuals.
Now, more information on the prothrombotic disorder has become available. The vaccine appears to be linked to a condition that clinically resembles heparin-induced thrombocytopenia (HIT) and that occurs mainly in younger women.
Researchers have described clinical and laboratory details of nine patients from Germany and Austria who developed this condition 4 to 16 days after receiving the AstraZeneca vaccine in a preprint article published March 28 on Research Square.
They found that serum from four patients who were tested showed platelet-activating antibodies directed against platelet factor 4 (PF4), similar to what is seen in HIT.
They are proposing naming the condition “vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)” to avoid confusion with hit.Till date we understand that these breakthrough infections are not severe and complications of thrombosis is very rare .
Solution

1)Though risk benefits ratio still favors use of AstraZeneca vaccination but this question should be analyzed systematically in India . In India maximum number of Covishield jab has been given and our genetic constitution is different from European.

2)Also this problem can be solved by availability of other vaccines like Johnson and Johnson , Pfizer in Indian markets .


3) Indian govt already has all the data of vaccines recipients- without delay they should immediately conduct survey regarding breakthrough infections. This is very easy to conduct as all positive reports are reported / linked with Aadhar card and phone numbers . Govt just need to link both data .

We need to put end to these rumours to decrease vaccine hesitancy .

The writer is Dr Dhiren Gupta, Senior, Pediatrician, Sir Gangaram Hospital.

0 comment
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts
What Happens When You Lack Vitamin A In Your Body? 5 Signs to Watch Out For Why Breast Cancer Screening at 40 is a Life-Saving Choice Avoid These Food and Medicine Combos Identifying Rheumatoid Arthritis: Early Signs and Symptoms to Watch For “Delicious Diabetes-Friendly Smoothies: 5 Homemade Recipes to Satisfy Your Sweet Tooth Without Spiking Blood Sugar”